期刊文献+

联合检测AFP与ICAM-1在原发性肝癌根治性切除术后复发的意义 被引量:3

Significance of AFP and ICAM-1 Monitoring in Recurrence Primary Liver Caner after Radical Resection
下载PDF
导出
摘要 目的测定血清甲胎蛋白(AFP)和细胞间黏附分子-1(ICAM-1)在肝细胞肝癌(HCC)复发前后的变化,探讨其在复发监测中的价值。方法对手术后复发的44例肝癌患者的血AFP与ICAM-1水平进行回顾性研究分析。结果当确诊为肝癌复发时,AFP的水平明显低于术前(P<0.01),ICAM-1的水平低于术前(P<0.05);AFP阳性例数为23例,Ⅰ- CAM-1阳性例数为36例,ICAM-1的阳性率高于AFP(P<0.01),两者中任一项阳性病例共42例,高于ICAM-1(P<0.05)或AFP(P<0.05)单独的阳性率。结论肝癌复发早期诊断中,ICAM-1的意义大于AFP,尤其是AFP阴性的患者,两者联合检测的价值高于两者任何之一。 Objective To determination the clinical value of serum α-fetoprotein(AFP) and intercellular adhesion molecule-1(ICAM-1)in monitoring postoperative recurrence of hepatocellular carcinoma(HCC). Methods Retrospectively analysed the level of plasma AFP and ICAM-1 of 44 patients who had been suffered from the hepatic carcinoma operation and relapse. Results When the recurrence was confirmed,the level of AFP was much lower significantly than the level before operation(P〈0.01) ;the level of ICAM-1 was lower significantly than the level before operation(P〈0.05). The patients of positive AFP were 23,while ICAM-1 were 36,the positive rate of ICAM-1 was higher than the AFP(P〈0. 01),and any one of the two parameters were 42,the positive rate was higher than anyone of the twoparameters(P〈0. 05). Conclusion When the early diagnosis of the recurrence of hepatic carcinoma after operation can be needed,the worth of ICAM-1 is greater than the AFP,particularly for those patients with AFP negative and when the two parameters are combined ,the worth much greater than anyone.
出处 《现代检验医学杂志》 CAS 2007年第4期83-84,共2页 Journal of Modern Laboratory Medicine
关键词 肝细胞癌 复发 AFP ICAM-1 hepatocellular carcinoma relapse AFP ICAM-1
  • 相关文献

参考文献5

二级参考文献11

共引文献112

同被引文献24

  • 1袁林,沈世强,熊成龙,王军.E-钙黏蛋白在肝细胞癌中的表达及临床意义[J].临床外科杂志,2004,12(7):407-408. 被引量:4
  • 2劳明,朱波,黄玲莎,黄文成,李佩章,赵惠柳.三种肿瘤标志物联合检测对原发性肝癌的诊断价值[J].中华消化杂志,2005,25(2):109-110. 被引量:38
  • 3Geng X, Wang F, Li YG, et al. Seldi-tof ms proteinehip technology for screening of serum markers of HBV-induced hepatocellular carcinoma[J]. Exp Clin Cancer Res,2007,26(4) :505-508.
  • 4Yu MW, Yeh SH,Chen PJ,et al. Hepatitis B virus genotype and DNA level and hepatocellular earcinoma:a prospective study in men [ J ]. Nail Cancer Inst,2005,97 (4) :265-272.
  • 5Jang JW, Choi JY, Bae SH,et al. The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatecellular carcinoma who receive transarterial chcmolipiodolization: implications for viral suppression to reduce the risk of cancer recurrence [J]. Cancer,2007,110(8) :1760-1767.
  • 6Chang CH,Chau GY,Lui WY,et al. Long-term results of hepatic resection for hepatoeellular carcinoma originating from the noncirrhotic liver[J]. Arch Surg,2004,139(3 ) :320-325.
  • 7Chen JD,Liu CJ,Lee PH,et al. Hepatitis B genotypes correlate with tumor recurrenee after curative resection of hepatoe.ellular carcinoma [ J]. Clin Gastroenterol Hepatol,2004,2( 1 ) :64-71.
  • 8Sun HC, Zhang W, Qin LX. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma[J]. Hepatol, 2007,47(5) :684-690.
  • 9Chemin I, Trepa C. Clinical impact of occult HBV infections [J]. J Clin Virol, 2005,34( 11 ) :15-17.
  • 10Carlos Rodríguez de Lope,Silvia Tremosini,Alejandro Forner,María Reig,Jordi Bruix.Management of HCC[J]. Journal of Hepatology . 2012

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部